Your browser doesn't support javascript.
loading
Brain iron chelation by deferiprone in a phase 2 randomised double-blinded placebo controlled clinical trial in Parkinson's disease.
Martin-Bastida, Antonio; Ward, Roberta J; Newbould, Rexford; Piccini, Paola; Sharp, David; Kabba, Christina; Patel, Maneesh C; Spino, Michael; Connelly, John; Tricta, Fernando; Crichton, Robert R; Dexter, David T.
Afiliação
  • Martin-Bastida A; Centre for Neuroinflammation & Neurodegeneration, Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
  • Ward RJ; Centre for Neuroinflammation & Neurodegeneration, Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
  • Newbould R; Universite Catholique de Louvain, 1348, Louvain-la-Neuve, Belgium.
  • Piccini P; Imanova Ltd, Burlington Danes Building, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
  • Sharp D; Centre for Neuroinflammation & Neurodegeneration, Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
  • Kabba C; Centre for Neuroinflammation & Neurodegeneration, Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
  • Patel MC; Centre for Neuroinflammation & Neurodegeneration, Division of Brain Sciences, Faculty of Medicine, Imperial College London, Hammersmith Hospital Campus, Du Cane Road, London, W12 0NN, UK.
  • Spino M; Imaging Department, Charing Cross Hospital, Imperial College NHS Trust, Fulham Palace Road, London, W6 8RF, UK.
  • Connelly J; ApoPharma Inc. 200 Barmac Drive, Toronto, Ontario, M9L 2Z7, Canada.
  • Tricta F; ApoPharma Inc. 200 Barmac Drive, Toronto, Ontario, M9L 2Z7, Canada.
  • Crichton RR; ApoPharma Inc. 200 Barmac Drive, Toronto, Ontario, M9L 2Z7, Canada.
  • Dexter DT; Universite Catholique de Louvain, 1348, Louvain-la-Neuve, Belgium.
Sci Rep ; 7(1): 1398, 2017 05 03.
Article em En | MEDLINE | ID: mdl-28469157
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Piridonas / Química Encefálica / Quelantes de Ferro / Ferro Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Piridonas / Química Encefálica / Quelantes de Ferro / Ferro Tipo de estudo: Clinical_trials / Observational_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Sci Rep Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Reino Unido País de publicação: Reino Unido